BOSTON & CAMBRIDGE, England--(BUSINESS WIRE)--Cycle Pharmaceuticals Ltd (“Cycle”), a dynamic leader in developing rare disease therapies, today reaffirmed its proposal to acquire all of the ...

BOSTON, April 22, 2025--(BUSINESS WIRE)--Cycle Pharmaceuticals (Cycle) has launched Cycle Vita PKU, an AI-powered app to help patients with PKU manage every aspect of their treatment plan.

Cambridge & Coventry, UK, 5th May 2020 / Sciad Newswire / Cycle Pharmaceuticals Ltd (Cycle) and Medherant Ltd (Medherant) are pleased to announce that they have signed an agreement to develop and ...

(Reuters) -Vanda Pharmaceuticals on Monday rejected UK-based Cycle Pharmaceuticals' second takeover proposal, which values the drugmaker at $8 per share despite a drop in Vanda's stock following ...

The full text of Cycle’s proposal delivered to Vanda’s Board on September 23, 2024 is below: Dear Mihael Polymeropoulos - Vanda Pharmaceuticals ... is headquartered in Cambridge, U.K. and ...

Unique transdermal delivery technology and medicines for rare diseases combine to deliver significant quality-of-life benefits for patients Cycle Pharmaceuticals Ltd (Cycle) and Medherant Ltd ...